Sign Up to like & get
recommendations!
1
Published in 2022 at "AJOB Empirical Bioethics"
DOI: 10.1080/23294515.2022.2110963
Abstract: Abstract Background When anti-cancer treatments have been given market authorization, but are not (yet) reimbursed within a healthcare system, physicians are confronted with ethical dilemmas. Arranging access through other channels, e.g., hospital budgets or out-of-pocket…
read more here.
Keywords:
yet reimbursed;
anti cancer;
access;
cancer treatments ... See more keywords